Ebb & Flow

Even when many companies continue to land big financing rounds, sometimes it's best to stop fishing for money. With one good deal in hand, investors in Cardion concluded that it was time to fold up the tent.

The German stem cell and gene therapy play has given up its R&D and has been turned from an AG into a GmbH shell, following a decision by its investors not to put additional money into the company...